Dew, re. "U.S. ATryn time line" I believe the FDA trial would start in PIII.
Are you referring to studies for FDA approval in the DIC indication? What are people's thoughts? With data from the Phase II studies conducted by LEO in Europe, how much addtional work will the FDA require of GTC(+partner) in the US?